Calpain restrains the stem cells compartment in breast cancer

References

• Bertoli C, Copetti T, Lam EW, Demarchi F, Schneider C. Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A. Oncogene 2009; 28:721–33; PMID:19029949; http://dx.doi.org/10.1038/onc.2008.425
   PubMed Web of Science ®Google Scholar
• Cataldo F, Peche LY, Klaric E, Brancolini C, Myers MP, Demarchi F, Schneider C. CAPNS1 regulates USP1 stability and maintenance of genome integrity. Mol Cell Biol 2013; 33:2485–96; PMID:23589330; http://dx.doi.org/10.1128/MCB.01406-12
   PubMed Web of Science ®Google Scholar
• Chen J, Dexheimer TS, Ai Y, Liang Q, Villamil MA, Inglese J, Maloney DJ, Jadhav A, Simeonov A, Zhuang Z, Selective and cell-active inhibitors of the USP1/ UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells. Chem Biol 2011; 18:1390–400; PMID:22118673; http://dx.doi.org/10.1016/j.chembiol.2011.08.014
   PubMed Web of Science ®Google Scholar
• Cortesio CL, Boateng LR, Piazza TM, Bennin DA, Huttenlocher A. Calpain-mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration. J Biol Chem 2011; 286:9998–10006; PMID:21270128; http://dx.doi.org/10.1074/jbc.M110.187294
   PubMed Web of Science ®Google Scholar
• Fujita T, Liu W, Doihara H, Date H, Wan Y. Dissection of the APCCdh1-Skp2 cascade in breast cancer. Clin Cancer Res: An Off J Am Assoc Cancer Res 2008; 14:1966–75; PMID:18381934; http://dx.doi.org/10.1158/1078-0432.CCR-07-1585
   PubMed Web of Science ®Google Scholar
• Ho WC, Pikor L, Gao Y, Elliott BE, Greer PA. Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma. J Biol Chem 2012; 287:15458–65; PMID:22427650; http://dx.doi.org/10.1074/jbc.M112.349308
   PubMed Web of Science ®Google Scholar
• Insinga A, Cicalese A, Faretta M, Gallo B, Albano L, Ronzoni S, Furia L, Viale A, Pelicci PG. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions. Proc Natl Acad Sci U S A 2013; 110:3931–6; PMID:23417300; http://dx.doi.org/10.1073/pnas.1213394110
   PubMed Web of Science ®Google Scholar
• Kechad A, Jolicoeur C, Tufford A, Mattar P, Chow RW, Harris WA, Cayouette M. Numb is required for the production of terminal asymmetric cell divisions in the developing mouse retina. J Neurosci: Off J Soc Neurosci 2012; 32:17197–210; PMID:23197712; http://dx.doi.org/10.1523/JNEUROSCI.4127-12.2012
   PubMed Web of Science ®Google Scholar
• Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 2007; 4:359–65; PMID:17396127; http://dx.doi.org/10.1038/nmeth1015
   PubMed Web of Science ®Google Scholar
• Lerner RG, Petritsch C. A microRNA-operated switch of asymmetric-to-symmetric cancer stem cell divisions. Nat Cell Biol 2014; 16:212–4; PMID:24576899; http://dx.doi.org/10.1038/ncb2924
   PubMed Web of Science ®Google Scholar
• Maestre C, Delgado-Esteban M, Gomez-Sanchez JC, Bolanos JP, Almeida A. Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J 2008; 27:2736–45; PMID:18818692; http://dx.doi.org/10.1038/emboj.2008.195
   PubMed Web of Science ®Google Scholar
• Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Ryden L, Luts L, Bendahl PO, Hedenfalk I. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer. Breast Cancer Res Treat 2010; 122:315–24; PMID:19795205; http://dx.doi.org/10.1007/s10549-009-0568-x
   PubMed Web of Science ®Google Scholar
• Shen Q, Zhong W, Jan YN, Temple S. Asymmetric Numb distribution is critical for asymmetric cell division of mouse cerebral cortical stem cells and neuroblasts. Development 2002; 129:4843–53; PMID:12361975
   PubMed Web of Science ®Google Scholar
• Sorimachi H, Hata S, Ono Y. Expanding members and roles of the calpain superfamily and their genetically modified animals. Exp Anim 2010; 59:549–66; PMID:21030783; http://dx.doi.org/10.1538/expanim.59.549
   PubMed Web of Science ®Google Scholar
• Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG. The calpain system and cancer. Nat Rev Cancer 2011a; 11:364–74; PMID:21508973; http://dx.doi.org/10.1038/nrc3050
   PubMed Web of Science ®Google Scholar
• Storr SJ, Woolston CM, Barros FF, Green AR, Shehata M, Chan SY, Ellis IO, Martin SG. Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy. Int J Cancer. J Int du Cancer 2011b; 129:1773–80; PMID:21140455; http://dx.doi.org/10.1002/ijc.25832
   PubMed Web of Science ®Google Scholar
• Storr SJ, Lee KW, Woolston CM, Safuan S, Green AR, Macmillan RD, Benhasouna A, Parr T, Ellis IO, Martin SG. Calpain system protein expression in basal-like and triple-negative invasive breast cancer. Ann Oncol: Off J Euro Soc Med Oncol/ESMO 2012; 23:2289–96; PMID: 22745213; http://dx.doi.org/10.1093/annonc/mds176
   PubMed Web of Science ®Google Scholar
• Wazir U, Jiang WG, Sharma AK, Newbold RF, Mokbel K. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer. Anticancer Res 2013; 33:2179–83; PMID:23645773
   PubMed Web of Science ®Google Scholar
• Williams SA, Maecker HL, French DM, Liu J, Gregg A, Silverstein LB, Cao TC, Carano RA, Dixit VM. USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. Cell 2011; 146:918–30; PMID:21925315; http://dx.doi.org/10.1016/j.cell.2011.07.040
   PubMed Web of Science ®Google Scholar